HBME-1 Immunostaining in Thyroid Tumors Especially in Follicular Neoplasm-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HBME-1 Immunostaining in Thyroid Tumors Especially in Follicular Neoplasm

Published:2003 Issue:2 Volume:50 Page:173-177
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

MASE TAKAHIRO¹,FUNAHASHI HIROOMI²,KOSHIKAWA TAKASHI³,IMAI TSUNEO²,NARA YOSHIHARU⁴,TANAKA YUJI⁵,NAKAO AKIMASA²

Affiliation:

1. Department of Surgery, Atsumi Hospital

2. Department of Surgery II, Nagoya University School of Medicine

3. Aichi Prefecture College of Nursing and Health

4. Department of Pathology, Yokkaichi Municipal Hospital

5. Department of Surgery, Tajimi Daiichi Hospital

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/50/2/50_2_173/_pdf

Reference19 articles.

1. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma

2. 5. Hedinger Chr, Williams ED, Sobin LH (1988) Histological Typing of Thyroid Tumors. 2nd ed. Geneva: WHO.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EphB3 protein is a potential ancillary diagnostic biomarker for thyroid cancers;Annals of Diagnostic Pathology;2024-04

2. Identification of invasive subpopulations using spatial transcriptome analysis in thyroid follicular tumors;Journal of Pathology and Translational Medicine;2024-01-15

3. Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology;Expert Review of Proteomics;2023-11-29

4. Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples;Endocrine Pathology;2022-05-21

5. Lights on HBME-1: the elusive biomarker in thyroid cancer pathology;Journal of Clinical Pathology;2022-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3